Tetanus is among the many diseases for which the U.S. Centers for Disease Control and Prevention (CDC) recommend routine vaccination. Like all CDC-recommended vaccines, the tetanus vaccines (including DTaP, DTP, DT, Td and TT) are generally considered safe, but they present risks for certain injuries and illnesses in a very small percentage of cases. In this article, vaccine lawyer Leah Durant explains the process of seeking compensation for tetanus vaccine injuries under the National Vaccine Injury Compensation Program (VICP). Continue reading
The U.S. Centers for Disease Control and Prevention (CDC) recently published an updated version of its guide for parents titled, Your Child’s First Vaccines: What You Need to Know. In addition to being posted on the CDC’s website, the guide is also available in .PDF format, and the CDC encourages doctors to provide parents with a copy of the guide when they bring their children in for their first immunizations. Continue reading
Vasovagal syncope, a condition that results in fainting due to a sudden drop in heart rate and blood pressure, is a condition that has been linked to several of the standard vaccinations that are recommended by the U.S. Centers for Disease Control and Prevention (CDC). While only a very small percentage of vaccine recipients will experience vasovagal syncope as a result of their vaccinations, for those that do, the consequences can potentially be severe. Continue reading
In late 2018, the U.S. Food and Drug Administration (FDA) announced expanded approval of the Gardasil 9 human papilloma virus (HPV) vaccine. Previously approved for administration to males and females between the ages of 9 and 26, Gardasil 9 is now an approved HPV vaccine for men and women through 45 years of age.
According to the FDA’s press release:
“[The] approval represents an important opportunity to help prevent HPV-related diseases and cancers in a broader age range. . . . The Centers for Disease Control and Prevention has stated that HPV vaccination prior to becoming infected with the HPV types covered by the vaccine has the potential to prevent more than 90 percent of these cancers, or 31,200 cases every year, from ever developing.”